|
Volumn 29, Issue 11, 2011, Pages 967-969
|
In vogue with venture
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE INHIBITOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CEPHALOSPORIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
IMATINIB;
IMIGLUCERASE;
ORPHAN DRUG;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PLEXXIKON;
SAXAGLIPTIN;
SITAGLIPTIN;
UNCLASSIFIED DRUG;
BIOMEDICINE;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
GAUCHER DISEASE;
MELANOMA;
MYELOID LEUKEMIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
ONCOLOGY;
PRIORITY JOURNAL;
CLINICAL TRIALS, PHASE II AS TOPIC;
DRUG DISCOVERY;
DRUG INDUSTRY;
HEALTH CARE SECTOR;
HUMANS;
THERAPIES, INVESTIGATIONAL;
|
EID: 80755189326
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2048 Document Type: Note |
Times cited : (1)
|
References (0)
|